# US 2016/0354299 A1 · Skin-care formulation for treating anti-aging and wrinkle reduction

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0354299 A1
- Document ID: US20160354299A1
- Status: Published application
- Kind: A1
- Application number: 15/175,461
- Filed: 2016-06-07
- Published: 2016-12-08
- Earliest claimed: 2015-06-08
- Inventors: Maryam Ershadi; Emanuel Itzhakian
- Web page: https://patentgrep.com/patent/US20160354299A1

## CPC

- A61K 8/64: Proteins; Peptides; Derivatives or degradation products thereof
- A61K 8/19: containing inorganic ingredients
- A61K 8/345: {containing more than one hydroxy group}
- A61K 8/365: Hydroxycarboxylic acids; Ketocarboxylic acids
- A61K 8/44: Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K 8/4946: {Imidazoles or their condensed derivatives, e.g. benzimidazoles}
- A61K 8/498: {having 6-membered rings or their condensed derivatives, e.g. coumarin}
- A61K 8/73: Polysaccharides
- A61K 8/735: {Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof}
- A61K 8/97: from algae, fungi, lichens or plants; from derivatives thereof
- A61K 8/987: {of species other than mammals or birds}
- A61K 8/988: {Honey; Royal jelly, Propolis}
- A61Q 19/08: Anti-ageing preparations
- A61K 2800/59: Mixtures
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The present disclosure relates to skincare products for treating the aging related issues of wrinkles or accidents such as scarring or burning and more specifically to specific formulations used to improve user outcomes in regards to skin elasticity, appearance and/or hydration. The contemplated products relate to formulations including combinations of biomimetic peptides and proteins of naturally occurring venoms in various known wildlife including bees, wasps, snakes, or snails, in a single formulation or in combination with various plant related ingredients with various carrier and/or medicament ability.

## Claims

### Claim 1

A formulation comprising:
a therapeutically effective amount of apitoxin;
a therapeutically effective amount of a Glycerin, Aqua, Dipeptide Diaminobutyroyl Benzylamide Diacetate equivalent biomimetic peptide; and
a therapeutically effective amount of μconotoxin CnCIII.

### Claim 2 (depends on 1)

The formulation of claim 1, wherein the therapeutically effective amount of apitoxin is between 0.01-1.00% within the formulation, the therapeutically effective amount of Glycerin, Aqua, Dipeptide Diaminobutyroyl Benzylamide Diacetate is between 1.00-8.00% within the formulation and the therapeutically effective amount of μconotoxin CnCIII is between 1.00-8.00% within the formulation.

### Claim 3 (depends on 1)

The formulation of claim 1, further comprises a therapeutically effective amount of at least one ingredient selected from a list consisting of 1) allantoin, 2) Glycerin, Albizia Julibrissin Bark Extract, Darutoside, 3) Glycerin, Royal Jelly, 4) Glycerin, Aqua, Terminalia Ferdinandiana Fruit Extract, 5) Water, Glycerin, Citrus Aurantium Dulcis Callus Culture Extract, Xanthan Gum, 6) Magnesium Aspartate, Zinc Gluconate, Copper Gluconate, 7) sH-Ogliopeptide-1, 8) Rhododendron Ferrugineum Leaf Cell Culture Extract, 9) sodium hyaluronate, 10) honey extract and 11) caviar extract.

### Claim 4 (depends on 3)

The formulation of claim 3, wherein the therapeutically effective amount of allantoin is between 0.01-1.00% of the formulation, the therapeutically effective amount of Glycerin, Albizia Julibrissin Bark Extract, Darutoside is between 1.00-10.00% of the formulation, the therapeutically effective amount of Glycerin, Royal Jelly is between 0.01-3.00% of the formulation, the therapeutically effective amount of Glycerin, Aqua, Terminalia Ferdinandiana Fruit Extract is between 0.01-6.00% of the formulation, the therapeutically effective amount of Water, Glycerin, Citrus Aurantium Dulcis Callus Culture Extract, Xanthan Gum is between 0.20-6.00% of the formulation, the therapeutically effective amount of Magnesium Aspartate, Zinc Gluconate, Copper Gluconate is between 0.01-3.00% of the formulation, the therapeutically effective amount of sH-Ogliopeptide-1 is between 0.05-0.8mg of 100 g of the formulation, the therapeutically effective amount of Rhododendron Ferrugineum Leaf Cell Culture Extract is between 0.01-1.00% of the formulation, the therapeutically effective amount of Sodium Hyaluronate is between 0.10-3.00% of the formulation, the therapeutically effective amount of honey extract is between 0.10-1.50% of the formulation and the therapeutically effective amount of caviar extract is between 0.10-1.50% of the formulation if any of them is added to the formulation.

### Claim 5 (depends on 1)

The formulation of claim 1, further comprises at least one chelating agent.

### Claim 6 (depends on 5)

The formulation of claim 5, wherein the at least one chelating agent is Tetrasodium Glutamate Diacetate that has a percentage range of 0.01-1.00% within the formulation.

### Claim 7 (depends on 1)

The formulation of claim 1, further comprises deionized water that has a percentage range of 5-80% within the formulation.

### Claim 8 (depends on 1)

The formulation of claim 1, further comprises at least one type of emollient that has a percentage range of 0.50-7.00% within the formulation.

### Claim 9 (depends on 8)

The formulation of claim 8, wherein the at least one type of emollient is selected from a list consisting of Caprylic/Capric Triglyceride, Isononyl Isononanoate, Squalane and Pataua Oil.

### Claim 10 (depends on 1)

The formulation of claim 1, further comprises at least one type of emulsifier that has a percentage range of 1.00-10.00% within the formulation.

### Claim 11 (depends on 10)

The formulation of claim 10, wherein the at least one type of emulsifier is Hydrogenated Lecithin, C12-16 Alcohols, Palmitic Acid or Cetyl Alcohol, Glyceryl Stearate, PEG-75 Stearate, Ceteth-20, Steareth-2 or both.

### Claim 12 (depends on 1)

The formulation of claim 1, further comprises at least one a type of humectant, at least one a type of neutralizer, at least one a type of non-ionic surfactant/emulsifier and at least one a type of preservative.

### Claim 13 (depends on 1)

The formulation of claim 1, further comprises at least one a type of rheology modifier and at least one a type of sensorial modifier or mattifying agent.

### Claim 14

A formulation comprising:
0.01-1.00% of apitoxin;
1.00-8.00% of Glycerin, Aqua, Dipeptide Diaminobutyroyl Benzylamide Diacetate;
1.00-8.00% of μconotoxin CnCIII; and
at least one ingredient selected from a list consisting of 1) allantoin, 2) Glycerin, Albizia Julibrissin Bark Extract, Darutoside, 3) Glycerin, Royal Jelly, 4) Glycerin, Aqua, Terminalia Ferdinandiana Fruit Extract, 5) Water, Glycerin, Citrus Aurantium Dulcis Callus Culture Extract, Xanthan Gum, 6) Magnesium Aspartate, Zinc Gluconate, Copper Gluconate, 7) sH-Ogliopeptide-1, 8) Rhododendron Ferrugineum Leaf Cell Culture Extract, 9) sodium hyaluronate, 10) honey extract and 11) caviar extract.

### Claim 15 (depends on 14)

The formulation of claim 14, wherein the therapeutically effective amount of allantoin is between 0.01-1.00% of the formulation, the therapeutically effective amount of Glycerin, Albizia Julibrissin Bark Extract, Darutoside is between 1.00-10.00% of the formulation, the therapeutically effective amount of Glycerin, Royal Jelly is between 0.01-3.00% of the formulation, the therapeutically effective amount of Glycerin, Aqua, Terminalia Ferdinandiana Fruit Extract is between 0.01-6.00% of the formulation, the therapeutically effective amount of Water, Glycerin, Citrus Aurantium Dulcis Callus Culture Extract, Xanthan Gum is between 0.20-6.00% of the formulation, the therapeutically effective amount of Magnesium Aspartate, Zinc Gluconate, Copper Gluconate is between 0.01-3.00% of the formulation, the therapeutically effective amount of sH-Ogliopeptide-1 is between 0.05-0.8mg of 100 g of the formulation, the therapeutically effective amount of Rhododendron Ferrugineum Leaf Cell Culture Extract is between 0.01-1.00% of the formulation, the therapeutically effective amount of Sodium Hyaluronate is between 0.10-3.00% of the formulation, the therapeutically effective amount of honey extract is between 0.10-1.50% of the formulation and the therapeutically effective amount of caviar extract is between 0.10-1.50% of the formulation if any of them is added to the formulation.

### Claim 16 (depends on 14)

The formulation of claim 14, further comprises at least one type of emollient selected from a list consisting of Caprylic/Capric Triglyceride, Isononyl Isononanoate, Squalane and Pataua Oil.

### Claim 17 (depends on 14)

The formulation of claim 14, further comprises at least one type of emulsifier, at least one a type of humectant, at least one a type of neutralizer, at least one a type of nonionic surfactant/emulsifier, at least one a type of preservative, at least one a type of rheology modifier and at least one a type of sensorial modifier or mattifying agent.

### Claim 18

A formulation comprising:
0.01-1.00% of apitoxin;
1.00-8.00% of Glycerin, Aqua, Dipeptide Diaminobutyroyl Benzylamide Diacetate;
1.00-8.00% of μconotoxin CnCIII; and
at least one ingredient selected from a list consisting of:
1) 0.01-1.00% of allantoin,
2) 1.00-10.00% of Glycerin, Albizia Julibrissin Bark Extract, Darutoside,
3) 0.01-3.00% of Glycerin, Royal Jelly,
4) 0.01-6.00% of Glycerin, Aqua, Terminalia Ferdinandiana Fruit Extract, 5) 0.20-6.00% of Water, Glycerin, Citrus Aurantium Dulcis Callus Culture Extract, Xanthan Gum,
6) 0.01-3.00% of Magnesium Aspartate, Zinc Gluconate, Copper Gluconate,
7) 0.05-0.8mg of sH-Ogliopeptide-1 per every 100g of the formulation,
8) 0.01-1.00% of Rhododendron Ferrugineum Leaf Cell Culture Extract,
9) 0.10-3.00% of sodium hyaluronate,
10) 0.10-1.50% of honey extract,
11) 0.10-1.50% of caviar extract.

### Claim 19 (depends on 18)

The formulation of claim 18, further comprises at least one type of emollient, at least one type of emulsifier, at least one a type of humectant, at least one a type of neutralizer, at least one a type of non-ionic surfactant/emulsifier, at least one a type of preservative, at least one a type of rheology modifier and at least one a type of sensorial modifier or mattifying agent.

### Claim 20 (depends on 18)

The formulation of claim 18, further comprises aloe vera, amino acids, antioxidants and vitamins.
